Restart Life Sciences Corp.
HEAL
Kedudukan dalam Saham
#35831
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Harga Saham
$0.05137558
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$3.21M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
78.84%
Negara
CA
Perdagangan Restart Life Sciences Corp. (HEAL)
Kategori
Healthcare
Nisbah P/B bagi Restart Life Sciences Corp. (HEAL)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Restart Life Sciences Corp., nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk Restart Life Sciences Corp. dari 2026 hingga 2026
Nisbah P/B pada akhir setiap tahun
| Tahun | Nisbah P/B | Ubah |
|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | ||
Nisbah P/B untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/B | Perbezaan Nisbah P/B | Negara |
|---|---|---|---|
| 6.251 | - |
US
|
|
| 13.2547 | - |
US
|
|
| 4.208 | - |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | - |
NL
|
